Blockchain Registration Transaction Record

Anzor Pharmaceuticals CEO to Present Breakthrough Therapy at Chronic Kidney Disease Conference

Anzor Pharmaceuticals CEO presents groundbreaking FGF peptide therapy for chronic kidney disease at conference, offering hope for improved treatments. Learn more about the latest advancements in CKD research and potential impact on patient care.

Anzor Pharmaceuticals CEO to Present Breakthrough Therapy at Chronic Kidney Disease Conference

This news highlights the promising developments in FGF peptide therapy for chronic kidney disease, potentially offering new treatment options for the millions affected by this condition. The presentation's focus on addressing cardiovascular issues associated with CKD showcases the importance of innovative research in improving patient outcomes and quality of life.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x94a1f1fd6b6be5ea06a69cac5a119308e0cdd85d409aa072d8bee6e837162494
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintmilkWQRV-6432196c9843681572c9ee282ec7d7a3